Hollsteen
← Arista

D&A

Flow – sum over the period · $M

QuartersFiscal years

$MD&A · Q1 2016: $5.0M · 10-Q 0001596532-16-000255 filed May 5, 2016D&A · Q2 2016: $5.0M · derived · 10-Q 0001596532-17-000201 filed Aug 4, 2017D&A · Q3 2016: $5.0M · derived · 10-Q 0001596532-17-000251 filed Nov 3, 2017D&A · Q4 2016: $5.0M · derived · 10-K 0001596532-18-000018 filed Feb 20, 2018D&A · Q1 2017: $5.0M · 10-Q 0001596532-17-000088 filed May 8, 2017D&A · Q2 2017: $5.0M · derived · 10-Q 0001596532-18-000174 filed Aug 8, 2018D&A · Q3 2017: $5.0M · derived · 10-Q 0001596532-18-000233 filed Nov 5, 2018D&A · Q4 2017: $5.0M · derived · 10-K 0001596532-19-000027 filed Feb 15, 2019D&A · Q1 2018: $6.0M · 10-Q 0001596532-18-000109 filed May 4, 2018D&A · Q2 2018: $6.0M · derived · 10-Q 0001596532-19-000184 filed Aug 2, 2019D&A · Q3 2018: $7.0M · derived · 10-Q 0001596532-19-000230 filed Nov 1, 2019D&A · Q4 2018: $9.0M · derived · 10-K 0001596532-20-000024 filed Feb 14, 2020D&A · Q1 2019: $8.0M · 10-Q 0001596532-19-000104 filed May 6, 2019D&A · Q2 2019: $8.0M · derived · 10-Q 0001596532-20-000148 filed Aug 5, 2020D&A · Q3 2019: $8.0M · derived · 10-Q 0001596532-20-000226 filed Nov 3, 2020D&A · Q4 2019: $8.0M · derived · 10-K 0001596532-21-000049 filed Feb 19, 2021D&A · Q1 2020: $10.0M · 10-Q 0001628280-20-006504 filed May 6, 2020D&A · Q2 2020: $11.0M · derived · 10-Q 0001596532-21-000255 filed Aug 3, 2021D&A · Q3 2020: $11.0M · derived · 10-Q 0001596532-21-000354 filed Nov 2, 2021D&A · Q4 2020: $13.0M · derived · 10-K 0001596532-22-000026 filed Feb 15, 2022D&A · Q1 2021: $13.0M · 10-Q 0001596532-21-000149 filed May 6, 2021D&A · Q2 2021: $13.0M · derived · 10-Q 0001596532-22-000220 filed Aug 2, 2022D&A · Q3 2021: $13.0M · derived · 10-Q 0001596532-22-000294 filed Nov 1, 2022D&A · Q4 2021: $12.0M · derived · 10-K 0001596532-23-000016 filed Feb 14, 2023D&A · Q1 2022: $13.0M · 10-Q 0001596532-22-000112 filed May 3, 2022D&A · Q2 2022: $15.0M · derived · 10-Q 0001596532-23-000197 filed Aug 1, 2023D&A · Q3 2022: $17.0M · derived · 10-Q 0001596532-23-000274 filed Oct 31, 2023D&A · Q4 2022: $18.0M · derived · 10-K 0001596532-24-000043 filed Feb 13, 2024D&A · Q1 2023: $21.0M · 10-Q 0001596532-23-000104 filed May 2, 2023D&A · Q2 2023: $18.0M · derived · 10-Q 0001596532-24-000279 filed Jul 31, 2024D&A · Q3 2023: $17.0M · derived · 10-Q 0001596532-24-000368 filed Nov 8, 2024D&A · Q4 2023: $14.0M · derived · 10-K 0001596532-25-000028 filed Feb 19, 2025D&A · Q1 2024: $16.0M · 10-Q 0001596532-25-000106 filed May 7, 2025D&A · Q2 2024: $16.0M · derived · 10-Q 0001596532-25-000216 filed Aug 6, 2025D&A · Q3 2024: $16.0M · derived · 10-Q 0001596532-25-000286 filed Nov 5, 2025D&A · Q4 2024: $15.0M · derived · 10-K 0001596532-26-000013 filed Feb 17, 2026D&A · Q1 2025: $14.0M · 10-Q 0001596532-25-000106 filed May 7, 2025D&A · Q2 2025: $13.0M · derived · 10-Q 0001596532-26-000175 filed Aug 5, 2026D&A · Q3 2025: $23.0M · derived · 10-Q 0001596532-25-000286 filed Nov 5, 2025D&A · Q4 2025: $23.0M · derived · 10-K 0001596532-26-000013 filed Feb 17, 2026D&A · Q1 2026: $23.0M · 10-Q 0001596532-26-000078 filed May 6, 2026D&A · Q2 2026: $23.0M · derived · 10-Q 0001596532-26-000175 filed Aug 5, 20265.3a23.4a4.8Q1 2016Q2 2026Q3 2017
$MD&A · Q3 2016: $5.0M · derived · 10-Q 0001596532-17-000251 filed Nov 3, 2017D&A · Q4 2016: $5.0M · derived · 10-K 0001596532-18-000018 filed Feb 20, 2018D&A · Q1 2017: $5.0M · 10-Q 0001596532-17-000088 filed May 8, 2017D&A · Q2 2017: $5.0M · derived · 10-Q 0001596532-18-000174 filed Aug 8, 2018D&A · Q3 2017: $5.0M · derived · 10-Q 0001596532-18-000233 filed Nov 5, 2018D&A · Q4 2017: $5.0M · derived · 10-K 0001596532-19-000027 filed Feb 15, 2019D&A · Q1 2018: $6.0M · 10-Q 0001596532-18-000109 filed May 4, 2018D&A · Q2 2018: $6.0M · derived · 10-Q 0001596532-19-000184 filed Aug 2, 20195.3a5.6a5.1a5.7Q3 2016Q2 2018Q3 2017
Q3 2017
5.3a$M
derived
All values (42)
PeriodValue ($M)Status
Q2 202623.4derived
Q1 202623.3reported
Q4 202522.8derived
Q3 202523.2derived
Q2 202512.8derived
Q1 202513.8reported
Q4 202415.3derived
Q3 202415.6derived
Q2 202415.5derived
Q1 202415.6reported
Q4 202314.4derived
Q3 202317.0derived
Q2 202318.3derived
Q1 202320.9reported
Q4 202217.5derived
Q3 202217.2derived
Q2 202214.9derived
Q1 202213.1reported
Q4 202112.5derived
Q3 202112.6derived
Q2 202112.6derived
Q1 202112.7reported
Q4 202012.6derived
Q3 202010.8derived
Q2 202011.0derived
Q1 202010.2reported
Q4 20197.9derived
Q3 20198.2derived
Q2 20198.4derived
Q1 20198.4reported
Q4 20189.2derived
Q3 20187.1derived
Q2 20185.6derived
Q1 20185.7reported
Q4 20175.3derived
Q3 20175.3derived
Q2 20175.1derived
Q1 20174.9reported
Q4 20164.9derived
Q3 20165.1derived
Q2 20164.9derived
Q1 20164.8reported

CSV with all sources · Technical ID: dna

More metrics for Arista

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$5.0M (derived)
Period
Q3 2017, ended Sep 30, 2017 · quarterly value (3 months, not cumulative)
Calculation
Q3 = 9 months kumuliert − 6 months kumuliert = 15M − 10M = $5.0M (us-gaap:DepreciationDepletionAndAmortization; 9-Monats-Wert aus 0001596532-18-000233, Vorperiode aus dem vorherigen 10-Q)
Source
10-Q, filed Nov 5, 2018 · 0001596532-18-000233
Location
us-gaap:DepreciationDepletionAndAmortization
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$5.0MNov 5, 201810-Q 0001596532-18-000233derived · confidence 1. · current